SLHGF is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

16 institutions disclose a position in SLHGF, but none treat it as a major bet — even Raymond James & Associates, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Sfmg, LLC has trimmed its SLHGF position for two straight quarters, cutting it by $16.0K while still holding $9.0K.

Quarterly Activity

Recent Activity

+$44.0K

Total Buy Value

$4.0K

Total Sell Value

New buy3

Trim1

Add0

Sold out0

Net Buyers

Net Sellers

Smart Money Convergence

SLHGF does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2022-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/SLHGF

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

83086L205

FAQ

Who are the top institutional investors holding SKYLIGHT HEALTH GROUP INC (SLHGF)?

Major stakeholders currently include Raymond James & Associates ($41.0K), Citadel Advisors LLC ($34.0K), HighTower Advisors, LLC ($29.0K). Based on the latest 13F filings, there are a total of 16 tracked investment funds and institutions maintaining positions in SLHGF.

What is the overall institutional sentiment toward SLHGF recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $78.2K, driven by 3 managers accumulating shares while 1 reduced their exposure.

Which institutions have been selling or reducing their SLHGF positions?

In the latest period, 1 funds trimmed their holdings, and 0 managers completely exited their positions. The aggregate reported sell value was $4.0K.

Are there any notable investors adding SLHGF to their portfolios?

Yes, buying activity remains notable. 3 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $44.0K.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Popular on AlphaSMO

The most widely held stocks tracked across all 13F institutions

Procter & Gamble Co/the

Institutions Holding

3,978

Total reported value

$233.8B

Held by 3978 institutions — one of the most-tracked stocks on AlphaSMO

View detail

IVV

Ishares Core S&p 500 ETF

Institutions Holding

3,957

Total reported value

$554.5B

Held by 3957 institutions — one of the most-tracked stocks on AlphaSMO

View detail

QQQ

Invesco Qqq Trust Series 1

Institutions Holding

3,870

Total reported value

$390.8B

Held by 3870 institutions — one of the most-tracked stocks on AlphaSMO

View detail

Developer Access

Access SLHGF's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/SLHGF

CLI

npx alphasmo stocks get SLHGF

Full API & MCP documentation →